Studies of biological functions in blood cells from individuals with large platelets

Platelets

Volumn 14, Issue 7-8, 2003, Pages 413-419

  Breimo, Einar S ^a   Østerud, Bjarne ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CITRIC ACID; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; RANTES;

ADULT; ARTICLE; BLOOD CELL; CELL FUNCTION; CELL SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; THROMBOCYTE; THROMBOCYTE VOLUME;

ADULT; BLOOD CELL COUNT; BLOOD CELLS; BLOOD COAGULATION; BLOOD PLATELETS; CD40 LIGAND; CELL SIZE; COLLAGEN; DATA INTERPRETATION, STATISTICAL; EPINEPHRINE; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MALE; P-SELECTIN; PLATELET COUNT; PLATELET-DERIVED GROWTH FACTOR; RANTES; TUMOR NECROSIS FACTOR-ALPHA;

MOROCCAN PEPPER VIRUS;

EID: 0347933041     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.1080/02697450310001632597     Document Type: Article

References (38)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-9.
2. Ross R. Cell biology of atherosclerosis. Physiology 1995; 57: 791-804.
3. Weyrich A S, Elstad M R, McEver, R P, McIntyre T M, Moore K L, Morrisey J H, Prescott S M, Zimmermann G A. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest 1996; 97: 1525-34.
4. Apostolopoulos J, Davenport P, Tipping P G. Interleukin-8 production by macrophages from atheromatous plaques. Arterioscler Thromb Vasc Biol 1996; 16: 1007-12.
5. Liu Y, Hultén L M, Wiklund O. Macrophages isolated from human aterosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production. Arterioscler Thromb Vasc Biol 1997; 17: 317-23.
6. Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996; 127: 263-71.
7. Takeya M, Yoshimura T, Leonard E J, Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993; 24: 534-9.
8. Weksler B B. Platelets In: Gallin J K, Golstein I M, Synderman R, eds. Inflammation. Basic principles and clinical correlate. New York: New York Press, 1988; 543-57.
9. Halvorsen H, Olsen J O, Østerud B. Granulocytes enhance L PS-induced tissue factor activity in monocytes via an interaction with platelets. J Leucocyte Biol 1993; 54: 275-82.
10. Henn V, Slupsky J R, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek R A. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591-4.
11. Slupsky J R, Kalbas M, Willuweit A, Henn V, Kroczek R A, Muller-Berghaus G. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thromb Haemost 1998; 80: 1008-14.
12. Schonbeck U, Mach F, Sukhova G K, Herman M, Graber P, Kehry M R, Libby P. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. Am J Pathol 2000; 156: 7-14.
13. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arterioscler Thromb Vasc Biol 2000; 20: 2322-8.
14. Jakubowski J A, Thompson C B, Vaillancourt R, Valeri C R, Deykin D. Arachidonic acid metabolism by platelets of differing size. Br J Haematol 1983; 53: 503-11.
15. Martin J F, Trowbridge E A, Salmon G, Plumb J. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 1983; 32: 443-60.
16. Mathur A, Robinson M S, Cotton J, Martin J F, Erusalimsky J D. Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost 2001; 85: 989-94.
17. Pathanasali R, Smith N M, Bath P M. Prothrombotic megakaryocyte and platelet changes in hypertension are reversed following treatment: a pilot study. Platelets 2001; 12: 144-9.
18. Haver V M, Gear A R L. Functional fractionation of platelets. J Clin Lab Med 1981; 97: 187-204.
19. Smyth D W, Martin J F, Michalis L, Bucknall C A, Jewitt D E. Influence of platelet size before coronary angioplasty on subsequent restenosis. Eur J Clin Invest 1993; 23: 361-7.
20. Martin J F, Bath P M W, Burr M L. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-11.
21. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002; 117: 399-404.
22. Østerud B. A global view on the role of monocytes and platelets in atherogenesis. Thromb Res 1997; 85: 1-22.
23. Østerud B, Elvevoll E O, Brox J, Olsen J O. Cellular activation responses in blood in relation to lipid pattern: healthy men and women in families with myocardial infarction and cancer. Blood Coag Fibrinol 2002; 13: 399-405.
24. Østerud B. The high responder phenomenon: Enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. Platelets 1995; 6: 119-25.
25. Ernofsson M, Siegbahn A. Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thromb Res 1996; 83: 307-20.
26. Mhavech P, Saleem A. Inherited giant platelet disorders classification and literature review. Am J Clin Pathol 2000; 113: 176-90.
27. Solum N O. Procoagulant expression in platelets and defects leading to clinical disorders. Arterioscler Thromb Vasc Biol 1999; 19: 2841-6.
28. Engstad C E, Lund T, Østerud B. Epinephrine promotes IL-8 production in human leukocytes via an effect on platelets. Thromb Haemost 1999; 81: 139-45.
29. Johnson K, Aarden L, Choi Y, De groot E, Creasey A. The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87: 5051-60.
30. Stricter R M, Chensue S W, Standiford T J, Basha M A, Showell H J, Kunkel S L. Disparate gene expression of chemotactic cytokines by human mononuclear phagocytes. Biochem Biophys Res Commun 1990; 166: 886-91.
31. Brown A S, Hong Y, de Beider A, Beacon H, Beeso J, Sherwood R, Edmonds M, Martin J F, Erusalimsky J D. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 802-7.
32. Burstein S A. Effects of interleukin 6 on megakaryocytes and on canine platelet function. Stem Cells (Dayt) 1994; 12: 386-93.
33. van der Loo B, Martin J F. A role for changes in platelet production in the case of acute coronary syndromes. Arterioscler Thromb Vasc Biol 1999; 19: 672-9.
34. Chang M, Suen Y, Meng G, Buzby J S, Bussel J, Shen V, van de Ven C, Cairo M S. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood 1996; 88: 3354-62.
35. Lund T, Østerud B. The production of IL-8 in mononuclear cells and granulocytes stimulated with LPS, PMA and TNF-a. Haemostasis 2000; 30: 30-97.
36. Nomura S, Shozu A, Omoto S, Nishikawa M, Fukuhara S. Significance of chemocines and activated platelets in patients with diabetes. Clin Exp Immunol 2000; 121: 437-43.
37. Blann A D, Lip G Y H, Beevers D G, McCollum C N. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 1997; 77: 1077-80.
38. Fijnheer R, Frijns C J M, Korteweeg J, Rommes H, Peters J H, Sixma J J, Nieuwenhuis H K. The origin of P-selectin as circulating plasma protein. Thromb Haemost 1997; 77: 1081-5.